Skip to main content

A Metformin-Responsive Metabolic Pathway Controls Distinct Steps in Gastric Progenitor Fate Decisions and Maturation.

Citation
Miao, Z. -F., et al. “A Metformin-Responsive Metabolic Pathway Controls Distinct Steps In Gastric Progenitor Fate Decisions And Maturation.”. Cell Stem Cell, pp. 910-925.e6.
Center Washington University in St Louis
Author Zhi-Feng Miao, Mahliyah Adkins-Threats, Joseph R Burclaff, Luciana H Osaki, Jing-Xu Sun, Yan Kefalov, Zheng He, Zhen-Ning Wang, Jason C Mills
Keywords ADM, SPEM, mTORC1, metaplasia, mitochondria, paligenosis, ribosomes
Abstract

Cellular metabolism plays important functions in dictating stem cell behaviors, although its role in stomach epithelial homeostasis has not been evaluated in depth. Here, we show that the energy sensor AMP kinase (AMPK) governs gastric epithelial progenitor differentiation. Administering the AMPK activator metformin decreases epithelial progenitor proliferation and increases acid-secreting parietal cells (PCs) in mice and organoids. AMPK activation targets Krüppel-like factor 4 (KLF4), known to govern progenitor proliferation and PC fate choice, and PGC1α, which we show controls PC maturation after their specification. PC-specific deletion of AMPKα or PGC1α causes defective PC maturation, which could not be rescued by metformin. However, metformin treatment still increases KLF4 levels and suppresses progenitor proliferation. Thus, AMPK activates KLF4 in progenitors to reduce self-renewal and promote PC fate, whereas AMPK-PGC1α activation within the PC lineage promotes maturation, providing a potential suggestion for why metformin increases acid secretion and reduces gastric cancer risk in humans.

Year of Publication
2020
Journal
Cell stem cell
Volume
26
Issue
6
Number of Pages
910-925.e6
Date Published
06/2020
ISSN Number
1875-9777
DOI
10.1016/j.stem.2020.03.006
Alternate Journal
Cell Stem Cell
PMID
32243780
PMCID
PMC7275895
Download citation